Correlation between Deep Venous Thrombosis and Inflammation in Patients after Implantation of Permanent Pacemaker
Background: The correlation between postoperative deep venous thrombosis (DVT) and inflammation in patients with permanent cardiac pacemaker implantation was analyzed.
Methods: A total of 130 cases undergoing permanent pacemaker implantation in the 305 Hospital of Chinese PLA and Fuwai Hospital from May 2014 to February 2017 were selected. Of the 130 cases, 60 patients complicated with DVT were selected as the observation group, and the remaining 70 cases without complications of DVT were selected as the control group. The relationship and influence of various factors were explored.
Results: The number of patients smoking and the number of subjects with DVT history in the observation group were higher than those in the control group. In the observation group, plasminogen activator inhibitor (PAI)-1: Ag, PAI-1: Ac, thrombin-activated fibrinolysis inhibitor (TAFI): Ag, and TAFI: Ac levels were higher than those in control group (P<0.05). The levels of inflammatory factors of the peripheral blood of the observation group were significantly higher than those of the control group (P<0.05). In the correlation analysis of serum inflammatory factors and coagulation factors, CRP, IL-6, IL-10 were positively correlated with PAI-1: Ag level. Age, BMI, smoking history, number of implanted electrodes, DVT history, duration of immobilization and inflammatory factor levels had independent predictive value on postoperative complicated DVT.
Conclusion: The serum inflammatory factors are closely associated with postoperative DVT in patients implanted with permanent cardiac pacemaker, and the serum inflammatory factors are a good reference for the evaluation of DVT.
2. Squizzato A, Ageno W (2005). D-dimer test-ing in ischemic stroke and cerebral sinus and venous thrombosis. Semin Vasc Med, 5: 379-386.
3. Manly DA, Boles J, Mackman N (2011). Role of tissue factor in venous throm-bosis. Annu Rev Physiol, 73: 515-525.
4. Sideris S, Archontakis S, Dilaveris P, et al (2017). Leadless Cardiac Pacemakers: Current status of a modern approach in pacing. Hellenic J Cardiol, 58: 403-410.
5. Yoo MC, Cho YJ, Ghanem E, Ramteke A, kim kI (2009). Deep vein thrombosis af-ter total hip arthroplasty in korean pa-tients and D-dimer as a screening tool. Arch Orthop Trauma Surg, 129: 887-894.
6. Snow V, Qaseem A, Barry P, et al (2007). Joint American College of Physi-cians/american Academy of Family Phy-sicians Panel on Deep Venous Throm-bosis/pulmonary Embolism: Manage-ment of venous thromboembolism: A clinical practice guideline from the Ameri-can College of Physicians and the Ameri-can Academy of Family Physicians. Ann Fam Med, 5: 74-80.
7. Al Fagih A, Al Najashi K, Dagriri K, et al (2010). Feasibility of cardiac resynchroni-zation therapy in a patient with complex congenital heart disease and dextrocardia, facilitated bycardiac computed tomogra-phy and coronary sinus venography. Hel-lenic J Cardiol, 51: 178-182.
8. Yoshikane H, Yamamoto T, Ozaki M, Matsuzaki M (2007). Clinical significance of high‑sensitivity C‑reactive protein in lifestyle-related disease and metabolic syndrome. J Cardiol, 50: 175-182 (In Jap-anese).
9. Sidelmann JJ, Sjøland JA, Gram J, et al (2007). Lupus anticoagulant is significant-ly associated with inflammatory reactions in patients with suspected deep vein thrombosis. Scand J Clin Lab Invest, 67: 270-279.
10. Vormittag R, Vukovich T, Schönauer V, et al (2005). Basal high-sensitivity-C-reactive protein levels in patients with spontane-ous venous thromboembolism. Thromb Haemost, 93: 488-493.
11. Eren E, Yilmaz N, Pence S, Kocoglu H, Göksu S, Kocabaş R, Kadayifci S (2002). Diagnostic value of C-reactive protein in patients with angiographically document-ed coronary heart disease. Acta Medica (Hradec kralove), 45: 155-160.
12. Rozmus G, Daubert JP, Huang DT, Rosero S, Hall B, Francis C (2005). Venous thrombosis and stenosis after implanta-tion of pacemakers and defibrillators. J Interv Card Electrophysiol, 13: 9-19.
13. Peng WH, Chen GL, Zhou Y, Fan SY, Fu DL and Wang Y (2017). Study of expres-sion of circulating inflammatory factors in ACS rats with low dose of Tripterygi-um Wilfordii. Hellenic J Cardiol, 59: 46-47.
14. Kearon C (2001). Natural history of venous thromboembolism. Semin Vasc Med, 1: 27-37.
15. Syed FF, Beeching NJ (2005). Lower-limb deep-vein thrombosis in a general hospi-tal: Risk factors, outcomes and the con-tribution of intravenous drug use. QJM, 98: 139-145.
16. Whisenant B, kar S, Bunch TJ (2014). Left atrial appendage occlusion addresses the tremendous unmet needs of stroke pre-vention in atrial fibrillation that persist despite recent advances in anticoagulation therapy. Circulation, 130: 1516-1523.
17. Sabzi F, Faraji R (2013). Right atrial throm-bosis associated with sagittal sinus thrombosis caused by protein C-S defi-ciency. JNMA J Nepal Med Assoc, 52: 378-383.
18. Karatzis EN (2005). The role of inflamma-tory agents in endothelial function and their contribution to atherosclerosis. Hel-lenic J Cardiol, 46: 232-239.
19. Lim kE, Hsu WC, Hsu YY, Chu PH, Ng CJ (2004). Deep venous thrombosis: Com-parison of indirect multidetector CT ve-nography and sonography of lower ex-tremities in 26 patients. Clin Imaging, 28: 439-444.
20. Sidhu PS, Alikhan R, Ammar T, Quinlan DJ (2007). Lower limb contrast venography: A modified technique for use in throm-boprophylaxis clinical trials for the accu-rate evaluation of deep vein thrombosis. Br J Radiol, 80: 859-865.
|Issue||Vol 49 No 1 (2020)|
|Cardiac pacemaker implantation Deep venous thrombosis Inflammatory factors|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|